Skip to content

Epilepsy and Driving

Epilepsy and Driving

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07026591
Acronym
EPICO
Enrollment
40
Registered
2025-06-18
Start date
2025-11-06
Completion date
2027-11-30
Last updated
2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

Epilepsy can lead to cognitive impairments, particularly in attention, which may affect daily activities such as driving. Driving plays a key role in maintaining autonomy and is essential for the social and professional integration of people with epilepsy. Therefore, assessing fitness to drive is a major issue for individuals with epilepsy. French legislation governing driving for people with epilepsy clearly outlines the periods during which a person is not permitted to drive. However, the means or methods for evaluating driving fitness in these individuals are not well defined. Currently, assessment is based more on a medical consultation than on a comprehensive evaluation of driving ability. Using a driving simulator in combination with an EEG could be a valuable approach to better assess the impact of epilepsy-related cognitive impairments on driving performance.

Interventions

None listed

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild
Lead SponsorNETWORK

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged between 18 and 65 years * Holder of a category B driving license * Active driver: drives at least once a month * No medical condition contraindicating driving, except for epilepsy * Provides explicit consent to participate in the study * Affiliated with or a beneficiary of a social security scheme

Exclusion criteria

* Subject to legal protection (guardianship and curatorship are accepted for individuals with epilepsy, as this population represents a significant proportion of our institution's patients) * Pregnant or breastfeeding women * Known cybersickness (virtual reality or simulator sickness)

Design outcomes

Primary

MeasureTime frameDescription
SpeedDay 0Mean speed during the simulated driving task
Phasic alertnessDay 0Phasic alertness on neuropsychological test (TAP)
Lane positionDay 0Mean lane position during the simulated driving task
Braking timeDay 0Mean braking time during the simulated driving task
Information processing timeDay 0Mean information processing time during the simulated driving task
Sustained attentionDay 0Sustained attention on neuropsychological test (TAP)
Divided attentionDay 0Divided attention on neuropsychological test (TAP)
Visual scanningDay 0Visual scanning on neuropsychological test (TAP)

Countries

France

Contacts

Primary ContactAmelie Yavchitz
ayavchitz@for.paris+33 1 48 03 64 54

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026